The DOI matches its Crossref record; 435 of the 435 references it cites were found in a registry or an index.
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development
Open accessAbstract
Although much progress is being made in understanding the molecular pathways in the placenta that are involved in the pathophysiology of pregnancy-related disorders, a significant gap exists in the utilization of this information for the development of new drug therapies to improve pregnancy outcome. On March 5-6, 2015, the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health sponsored a 2-day workshop titled Placental Origins of Adverse Pregnancy Outcomes: Potential Molecular Targets to begin to address this gap. Particular emphasis was given to the identification of important molecular pathways that could serve as drug targets and the advantages and disadvantages of targeting these particular pathways. This article is a summary of the proceedings of that workshop. A broad number of topics were covered that ranged from basic placental biology to clinical trials. This included research in the basic biology of placentation, such as trophoblast migration and spiral artery remodeling, and trophoblast sensing and response to infectious and noninfectious agents. Research findings in these areas will be critical for the formulation of the development of future treatments and the development of therapies for the prevention of a number of pregnancy disorders of placental origin that include preeclampsia, fetal growth restriction, and uterine inflammation. Research was also presented that summarized ongoing clinical efforts in the United States and in Europe that has tested novel interventions for preeclampsia and fetal growth restriction, including agents such as oral arginine supplementation, sildenafil, pravastatin, gene therapy with virally delivered vascular endothelial growth factor, and oxygen supplementation therapy. Strategies were also proposed to improve fetal growth by the enhancement of nutrient transport to the fetus by modulation of their placental transporters and the targeting of placental mitochondrial dysfunction and oxidative stress to improve placental health. The roles of microRNAs and placental-derived exosomes, as well as messenger RNAs, were also discussed in the context of their use for diagnostics and as drug targets. The workshop discussed the aspect of safety and pharmacokinetic profiles of potential existing and new therapeutics that will need to be determined, especially in the context of the unique pharmacokinetic properties of pregnancy and the hurdles and pitfalls of the translation of research findings into practice. The workshop also discussed novel methods of drug delivery and targeting during pregnancy with the use of macromolecular carriers, such as nanoparticles and biopolymers, to minimize placental drug transfer and hence fetal drug exposure. In closing, a major theme that developed from the workshop was that the scientific community must change their thinking of the pregnant woman and her fetus as a vulnerable patient population for which drug development should be avoided, but rather be thought of as a deprived population in need of more effective therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–435 of 435
Pregnancy‐Associated Uterine Granulated Metrial Gland Cells in Mutant and Transgenic Mice
Guimond, M., Wang, B., Fujita, J., Terhorst, C., & Croy, B. A. (1996) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1996.tb00049.x · Cited by 37
Penetration of Pegylated Gold Nanoparticles Through Rat Placental Barrier
Tsyganova, N., Хайруллин, Р. М., Terentyuk, G. S., et al. (2014) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-014-2572-3 · Cited by 35
Schmella, M. J., Clifton, R. G., Althouse, A. D., & Roberts, J. M. (2015) · Reproductive Sciences · doi:10.1177/1933719115572477 · Cited by 35
Potter, J. A., Garg, M., Girard, S., & Abrahams, V. M. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.124032 · Cited by 35
Self-citationAnsari, T., Fenlon, S., Pasha, S., O'Neill, B., Gillan, J. E., Green, C. J., & Sibbons, P. D. (2003) · Placenta · doi:10.1016/s0143-4004(03)00044-4 · Cited by 33
TLR-4-Dependent and -Independent Mechanisms of Fetal Brain Injury in the Setting of Preterm Birth
Breen, K. E., Brown, A. G., Burd, I. D., Chai, J., Friedman, A., & Elovitz, M. A. (2012) · Reproductive Sciences · doi:10.1177/1933719112438439 · Cited by 32
Mulla, M. J., Myrtolli, K., Tadesse, S., Stanwood, N. L., Gariepy, A. M., Guller, S. M., Norwitz, E. R., & Abrahams, V. M. (2012) · American Journal of Reproductive Immunology · doi:10.1111/aji.12065 · Cited by 30
Self-citationEvaluation of Peritoneal Microbubble Oxygenation Therapy in a Rabbit Model of Hypoxemia
Legband, N. D., Feshitan, J. A., Borden, M. A., & Terry, B. S. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2388611 · Cited by 30
Subfertility Linked to Combined Luteal Insufficiency and Uterine Progesterone Resistance
Konno, T., Graham, A. R., Rempel, L. A., Ho-Chen, J. K., Alam, S. M. K., Bu, P., Rumi, M. A. K., & Soares, M. J. (2010) · Endocrinology · doi:10.1210/en.2010-0440 · Cited by 30
Self-citationPharmacogenetics and Individualizing Drug Treatment During Pregnancy
Haas, D. M. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.228 · Cited by 30
Self-citationAnimal models of deep trophoblast invasion
Pijnenborg, R., & Vercruysse, L. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511750847.014 · Cited by 30
A polypeptide drug carrier for maternal delivery and prevention of fetal exposure
George, E. M., Liu, H., Robinson, G. G., & Bidwell, G. L. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.950666 · Cited by 29
Self-citationKinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon
Zharikova, O. L., Ravindran, S., Nanovskaya, T. N., Hill, R. A., Hankins, G. D. V., & Ahmed, M. S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.03.005 · Cited by 28
Mayhew, T. (1991) · PubMed Central · Cited by 27
Adaptive history of single copy genes highly expressed in the term human placenta
Hou, Z., Romero, R. J., Uddin, M., Than, N. G., & Wildman, D. E. (2008) · Genomics · doi:10.1016/j.ygeno.2008.09.005 · Cited by 27
Small size‐specific umbilical vein diameter in severe growth restricted fetuses that die in utero
Rigano, S., Bozzo, M., Padoan, A., Mustoni, P., Bellotti, M., Galan, H. L., & Ferrazzi, E. M. (2008) · Prenatal Diagnosis · doi:10.1002/pd.2054 · Cited by 27
Bajoria, R., & Contractor, S. F. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06091.x · Cited by 27
Senadheera, S. N., Bertrand, P. P., Grayson, T., Leader, L. R., Murphy, T. V., & Sandow, S. L. (2013) · Journal of Anatomy · doi:10.1111/joa.12127 · Cited by 27
Yan, R., Nanovskaya, T. N., Zharikova, O. L., Mattison, D. R., Hankins, G. D. V., & Ahmed, M. S. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.01.013 · Cited by 26
Increased fetal leptin in Type I diabetes mellitus pregnancies complicated by chronic hypoxia
Hytinantti, T. K., Koistinen, H. A., Teramo, K. A., et al. (2000) · Diabetologia · doi:10.1007/s001250051367 · Cited by 25
Placental Drug Disposition and Its Clinical Implications
Zhou, S., Weier, N., He, S., Li, X., & Wang, L. (2008) · Current Drug Metabolism · doi:10.2174/138920008783571828 · Cited by 25
Global hormone profiling of murine placenta reveals Secretin expression
Knox, K., Leuenberger, D., Penn, A. A., & Baker, J. C. (2011) · Placenta · doi:10.1016/j.placenta.2011.08.013 · Cited by 22
Microbubble-mediated oxygen delivery to hypoxic tissues as a new therapeutic device
Bisazza, A., Giustetto, P., Rolfo, A., Caniggia, I., Balbis, S., Guiot, C., & Cavalli, R. (2008) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2008.4649599 · Cited by 20
Human Trophoblast Progenitors: Where Do They Reside?
Genbačev, O., Lamb, J. D., Prakobphol, A., Donne, M., McMaster, M., & Fisher, S. J. (2013) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1331798 · Cited by 19
Self-citationRytting, E., & Ahmed, M. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386007-1.00005-2 · Cited by 17
Self-citationCorrelation Between Umbilical Arterial Flow and Placental Morphology
Kreczy, A., Fusi, L., & Wigglesworth, J. S. (1995) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199510000-00004 · Cited by 17
Hirashima, C., Ohkuchi, A., Takahashi, K., Suzuki, H., Matsubara, S., & Suzuki, M. (2014) · Hypertension Research · doi:10.1038/hr.2014.31 · Cited by 17
Placenta-derived microparticles
Aharon, A., & Brenner, B. (2013) · Thrombosis Research · doi:10.1016/s0049-3848(13)70014-8 · Cited by 16
Pregnancy and Pharmacogenomics in the Context of Drug Metabolism and Response
Helldén, A., & Madadi, P. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.176 · Cited by 13
Assessing the Impact of the NIH CTSA Program on Institutionally Sponsored Clinical Trials
Liu, G., Chen, G., Sinoway, L. I., et al. (2013) · Clinical and Translational Science · doi:10.1111/cts.12029 · Cited by 10
Metabolism of bupropion by baboon hepatic and placental microsomes
Wang, X., Abdelrahman, D. R., Fokina, V. M., Hankins, G. D. V., Ahmed, M. S., & Nanovskaya, T. N. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.014 · Cited by 10
Metabolism and Disposition of Bupropion in Pregnant Baboons (Papio cynocephalus)
Rytting, E., Wang, X., Vernikovskaya, D. I., Zhan, Y., Bauer, C. A., Abdel‐Rahman, S. M., Ahmed, M. S., & Nanovskaya, T. N. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058255 · Cited by 9
Self-citationWang, X., Paul, J. A., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.04.030 · Cited by 6
Selection of Peptide Ligands for Human Placental Transcytosis Systems Using In Vitro Phage Display
Basha, S., Vaidhyanathan, S., & Pauletti, G. M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-012-6_8 · Cited by 3
Reed, M. D., & Mattison, D. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386007-1.00006-4 · Cited by 2
Cited by
Plasticenta: First evidence of microplastics in human placenta
Ragusa, A., Svelato, A., Santacroce, C., Catalano, P., Notarstefano, V., Carnevali, O., Papa, F., Rongioletti, M. C. A., Baiocco, F., Draghi, S., et al. (2021) · Environment International · doi:10.1016/j.envint.2020.106274 · Cited by 3,474
Grandi, S. M., Filion, K. B., Yoon, S., Ayele, H. T., Doyle, C. M., Hutcheon, J. A., Smith, G. N., Gore, G. C., Ray, J. G., Nerenberg, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036748 · Cited by 610
Detection of Microplastic in Human Placenta and Meconium in a Clinical Setting
Braun, T., Ehrlich, L., Henrich, W., Koeppel, S., Lomako, I., Schwabl, P., & Liebmann, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070921 · Cited by 511
Sangkham, S., Faikhaw, O., Munkong, N., Sakunkoo, P., Arunlertaree, C., Chavali, M., Mousazadeh, M., & Tiwari, A. (2022) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2022.113832 · Cited by 465
Tracking placental development in health and disease
Aplin, J. D., Myers, J. E., Timms, K., & Westwood, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0372-6 · Cited by 374
Metadata
- Authors
- Ilekis, J. V., Tsilou, E., Fisher, S., Abrahams, V. M., Soares, M. J., Cross, J. C., Zamudio, S., Illsley, N. P., Myatt, L., Colvis, C., Costantine, M. M., Haas, D. M., Sadovsky, Y., Weiner, C., Rytting, E., & Bidwell, G.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 215
- Issue
- 1
- Pages
- S1-S46
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2293304001
- Cited by
- 292
- References
- 435
- FWCI
- 32.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.